Todd Hagle, MD
Pain Medicine · Saint Charles, ILNPI 1609929462
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,674 of the $7,485 with a category attached, or 62.4%. It is spread thinly across 26 manufacturers, the largest accounting for just 21.1%. Reporting peaked in 2023 at $3,296 and has fallen 67.5% since, to $1,073 in 2025.
Across 149 payments — averaging $50.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Genesys Orthopedics Systems, L.L.C.$2K
- Relievant Medsystems, Inc.$942
- Boston Scientific$857
- Nevro Corp.$797
- Collegium Pharmaceutical, Inc.$535
- plus $1K from 20 others
What the payments were for
- Travel & lodging$2,76137%
- Food & beverage$4,67462%
- Education$350%
- Gifts$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 20 | $1,579 |
| Genesys Orthopedics Systems, L.L.C. | 9 | $1,572 |
| Relievant Medsystems, Inc. | 8 | $942 |
| Boston Scientific | 19 | $857 |
| Nevro Corp. | 15 | $797 |
| Collegium Pharmaceutical, Inc. | 36 | $535 |
| Globus Medical | 7 | $426 |
| Pfizer | 4 | $89 |
| MDD US Operations, LLC | 2 | $71 |
| AbbVie | 3 | $68 |
| Zavation Medical Products, LLC | 1 | $67 |
| Abbott | 3 | $67 |
| Biodelivery Sciences International, Inc. | 4 | $56 |
| Zyla Life Sciences, Inc. | 3 | $51 |
| Spinal Simplicity, LLC | 2 | $42 |
| Curonix LLC | 2 | $39 |
| Vertos Medical, Inc. | 1 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Surgenex LLC | 1 | $31 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Stimwave Technologies Incorporated | 1 | $20 |
| Novartis | 1 | $20 |
| Vertex | 1 | $18 |
| SPR Therapeutics, Inc | 1 | $18 |
| Stratus Medical, LLC | 1 | $15 |
| Saluda Medical Americas, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$3,095
- SACROILIAC JOINT FUSION SYSTEM$1,258
- ClosureFast$798
- Senza$557
- SYNCHROMEDII$160
- WaveWriter Alpha Prime 16$144
How this compares
$7,485 in reported general payments places this provider in the 75th percentile of 233 pain medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 513 | $14,560 |
| OxycontinOxycodone Hcl | 15 | $5,702 |
| Xtampza ErOxycodone Myristate | 15 | $5,700 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 152 | $4,263 |
| Celecoxib | 67 | $3,165 |
| Gabapentin | 220 | $2,890 |
| Baclofen | 191 | $2,846 |
| Duloxetine Hcl | 139 | $2,492 |
| Pregabalin | 153 | $2,308 |
| Oxycodone Hcl | 112 | $1,893 |
| Morphine Sulfate ErMorphine Sulfate | 84 | $1,547 |
| Cyclobenzaprine Hcl | 66 | $1,490 |
| Tramadol Hcl ErTramadol Hcl | 18 | $1,025 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 43 | $744 |
| Morphine Sulfate | 25 | $728 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $535 | $5,70015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 233 pain medicine providers in Illinois.
Other pain medicine in Saint Charles
- Ricardo VallejoBloomington$2.3M
- David DickersonEvanston$558K
- Thomas DahlbergRockford$218K
- Steven CohenChicago$217K
- Albert SinghQuincy$212K
- Nirav ShahSkokie$137K
- Ryan KutaNaperville$114K
- Anthony LebarioElgin$87K
- Keith SchmidtHoffman Estates$81K
- Jay HurhLibertyville$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.